Gene editing platform Specific Biologics raises follow-on funding
The round was backed by Canadian investors Lumira Ventures and adMare BioInnovations, which previously invested in the company in 2021.
16 October 2023•2 mins read
The round was backed by Canadian investors Lumira Ventures and adMare BioInnovations, which previously invested in the company in 2021.
